What is XXII's earnings growth forecast for 2026-2026?
(NASDAQ: XXII) 22nd Century Group's forecast annual earnings growth rate of N/A is not forecast to beat the US Tobacco industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
22nd Century Group's earnings in 2026 is -$34,525,000.
In 2026, XXII is forecast to generate -$41,511,611 in earnings, with the lowest earnings forecast at -$39,883,705 and the highest earnings forecast at -$42,732,541.
What is XXII's revenue growth forecast for 2026-2026?
(NASDAQ: XXII) 22nd Century Group's forecast annual revenue growth rate of N/A is not forecast to beat the US Tobacco industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
22nd Century Group's revenue in 2026 is $14,517,000.
In 2026, XXII is forecast to generate $23,668,901 in revenue, with the lowest revenue forecast at $22,740,709 and the highest revenue forecast at $24,365,045.
What is XXII's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: XXII) forecast ROA is -158.65%, which is lower than the forecast US Tobacco industry average of 22.52%.
What is XXII's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: XXII) 22nd Century Group's current Earnings Per Share (EPS) is -$539.00. In 2026, XXII's EPS is forecast to hit -$58.14 (min: -$55.86, max: -$59.85).
What is XXII's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: XXII) forecast ROE is -222.69%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.